Global Drug Repurposing Market Research Report By Types, Applications, Regions, Countries and Forecast to 2030

Global Drug Repurposing Market Research Report By Types, Applications, Regions, Countries and Forecast to 2030

Report Code: KNJ1751181 | No. of Pages: 110 | Category: Pharmaceuticals and Healthcare
Publisher: Knowledge Research | Date of Publish: Feb-2024
Drug Repurposing Market Research Report is a valuable source of perceptive data for business strategists. It provides industry overview with various point views; that include the availability of data, facts, and figures, past performance, trends, and way of approaching in the market. This research study of Drug Repurposing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, and present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

An in-depth analysis of global Drug Repurposing market presents in the report. An informative overview of market has been highlighted that sheds light on the market definition, application of the market offerings and the production methodology that is organized in the industry setting. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR for the period of 2024-2030.


Drug Repurposing Market Segmentation Analysis:

Market Segment by Type :-
Orally Drug
Intravenously Drug

Market Segment by Application:
Central Nervous Disorders
Cardiovascular Disorders
Oncology
Metabolic
Autoimmune
Other


Regional and Country-level Analysis
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA).
The report includes country-wise and region-wise market size for the period 2018-2030. It also includes market size and forecast in terms of sales and revenue for the period 2018-2030.


Competitive Landscape and Drug Repurposing Market Share Analysis
Drug Repurposing market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2018-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2018-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug Repurposing business, the date to enter into the Drug Repurposing market, Drug Repurposing product introduction, recent developments, etc.


The Major Key Players Covered:
Novartis AG
Sandoz
Johnson & Johnson
IBM
Abbott Healthcare
Teva Pharmaceuticals
Pfizer Inc.
Mylan Inc.
Hoffmann-La Roche
Astellas Pharma Inc.
Biovista
AbbVie Inc.
Allergan Plc.
NuMedii


FAQ'S
Q. 1. What is the vision of Drug Repurposing Market?
Q. 2. Does this report estimate the current market size?
Q. 3. Does the report delivers market size in terms of - Value (US$ Mn/Bn) and Volume of the market?
Q. 4. Who are the prominent players in the Drug Repurposing Market?
Q. 5. Which various segments are covered in Drug Repurposing Market?
Q. 6. What are the key factors covered in Drug Repurposing Market?
Q. 7. Does this report offer customization?

We can offer customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific requirements.
1 Report Overview
   1.1 Drug Repurposing Definition
   1.2 Market by Type
        1.2.1 Global Drug Repurposing Market Size Growth Rate by Type, 2018 VS 2022 VS 2030
        1.2.2 Orally Drug
        1.2.3 Intravenously Drug

  1.3 Market by Application
        1.3.1 Global Drug Repurposing Market Size Growth Rate by Application, 2018 VS 2022 VS 2030
        1.3.2 Central Nervous Disorders
        1.3.3 Cardiovascular Disorders
        1.3.4 Oncology
        1.3.5 IBMbolic
        1.3.6 Autoimmune
        1.3.7 Other

  1.4 Assumptions and Limitations
  1.5 Study Objectives
  1.6 Years Considered

 2 Global Drug Repurposing Sales
    2.1 Global Drug Repurposing Revenue Estimates and Forecasts 2018-2030
    2.2 Global Drug Repurposing Revenue by Region: 2018 VS 2022 VS 2030
    2.3 Global Drug Repurposing Revenue by Region
        2.3.1 Global Drug Repurposing Revenue by Region (2018-2023)
        2.3.2 Global Drug Repurposing Revenue by Region (2024-2030)
    2.4 Global Drug Repurposing Sales Quantity Estimates and Forecasts 2018-2030
    2.5 Global Drug Repurposing Sales Quantity by Region: 2018 VS 2022 VS 2030
    2.6 Global Drug Repurposing Sales Quantity by Region
        2.6.1 Global Drug Repurposing Sales Quantity by Region (2018-2023)
        2.6.2 Global Drug Repurposing Sales Quantity by Region (2024-2030)
    2.7 North America
    2.8 Europe
    2.9 APAC
    2.11 Middle East, Africa and Latin America

 3 Global Production (Based on Production Site)
    3.1 Global Drug Repurposing Production Value by Region: 2018 VS 2022 VS 2030
    3.2 Global Drug Repurposing Production Value by Region
        3.2.1 Global Drug Repurposing Historic Production Value by Region (2018-2023)
        3.2.2 Global Drug Repurposing Forecasted Production Value by Region (2024-2030)
    3.3 Global Drug Repurposing Production Capacity (2018-2030)
    3.4 Global Drug Repurposing Production by Region: 2018 VS 2022 VS 2030
    3.5 Global Drug Repurposing Production by Region
        3.5.1 Global Drug Repurposing Historic Production by Region (2018-2023)
        3.5.2 Global Drug Repurposing Forecasted Production by Region (2024-2030)
        3.5.3 North America
        3.5.4 Europe
        3.5.5 Japan
        3.5.6 China
        3.5.7 South Korea
        3.5.8 India

 4 Competition by Manufacturers
    4.1 Global Drug Repurposing Sales Quantity by Manufacturers
        4.1.1 Global Drug Repurposing Sales Quantity by Manufacturers (2018-2023)
        4.1.2 Global Drug Repurposing Sales Quantity Share by Manufacturers (2018-2023)
        4.1.3 Global Top 10 and Top 5 Companies by Drug Repurposing Sales in 2022
    4.2 Global Drug Repurposing Revenue by Manufacturers
        4.2.1 Global Drug Repurposing Revenue by Manufacturers (2018-2023)
        4.2.2 Global Drug Repurposing Revenue Share by Manufacturers (2018-2023)
        4.2.3 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2022
    4.3 Global Drug Repurposing Sales Price by Manufacturers
    4.4 Global Key Players of Drug Repurposing, Industry Ranking, 2021 VS 2022
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.6 Global Key Manufacturers of Drug Repurposing, Manufacturing Base Distribution and Headquarters
    4.7 Global Key Manufacturers of Drug Repurposing, Product Offered and Application
    4.8 Global Key Manufacturers of Drug Repurposing, Date of Enter into This Industry
    4.9 Mergers & Acquisitions, Expansion Plans

 5 Estimates and Forecasts by Type
    5.1 Global Drug Repurposing Sales Quantity by Type
        5.1.1 Global Drug Repurposing Historical Sales Quantity by Type (2018-2023)
        5.1.2 Global Drug Repurposing Forecasted Sales Quantity by Type (2024-2030)
        5.1.3 Global Drug Repurposing Sales Quantity Market Share by Type (2018-2030)
    5.2 Global Drug Repurposing Revenue by Type
        5.2.1 Global Drug Repurposing Historical Revenue by Type (2018-2023)
        5.2.2 Global Drug Repurposing Forecasted Revenue by Type (2024-2030)
        5.2.3 Global Drug Repurposing Revenue Market Share by Type (2018-2030)
    5.3 Global Drug Repurposing Price by Type
        5.3.1 Global Drug Repurposing Price by Type (2018-2023)
        5.3.2 Global Drug Repurposing Price Forecast by Type (2024-2030)

 6 Market Size by Application
    6.1 Global Drug Repurposing Sales Quantity by Application
        6.1.1 Global Drug Repurposing Historical Sales Quantity by Application (2018-2023)
        6.1.2 Global Drug Repurposing Forecasted Sales Quantity by Application (2024-2030)
        6.1.3 Global Drug Repurposing Sales Quantity Market Share by Application (2018-2030)
    6.2 Global Drug Repurposing Revenue by Application
        6.2.1 Global Drug Repurposing Historical Revenue by Application (2018-2023)
        6.2.2 Global Drug Repurposing Forecasted Revenue by Application (2024-2030)
        6.2.3 Global Drug Repurposing Revenue Market Share by Application (2018-2030)
    6.3 Global Drug Repurposing Price by Application
        6.3.1 Global Drug Repurposing Price by Application (2018-2023)
        6.3.2 Global Drug Repurposing Price Forecast by Application (2024-2030)

 7 North America
    7.1 North America Drug Repurposing Sales by Company
        7.1.1 North America Drug Repurposing Revenue by Company (2018-2023)
        7.1.2 North America Drug Repurposing Sales Quantity by Company (2018-2023)
    7.2 North America Drug Repurposing Market Size by Type
        7.2.1 North America Drug Repurposing Sales Quantity by Type (2018-2030)
        7.2.2 North America Drug Repurposing Revenue by Type (2018-2030)
    7.3 North America Drug Repurposing Market Size by Application
        7.3.1 North America Drug Repurposing Sales Quantity by Application (2018-2030)
        7.3.2 North America Drug Repurposing Revenue by Application (2018-2030)
    7.4 North America Drug Repurposing Market Size by Country
        7.4.1 North America Drug Repurposing Revenue by Country: 2018 VS 2022 VS 2030
        7.4.2 North America Drug Repurposing Revenue by Country (2018-2030)
        7.4.3 North America Drug Repurposing Sales Quantity by Country (2018-2030)
        7.4.4 U.S.
        7.4.5 Canada

 8 Europe
    8.1 Europe Drug Repurposing Sales by Company
        8.1.1 Europe Drug Repurposing Sales Quantity by Company (2018-2023)
        8.1.2 Europe Drug Repurposing Revenue by Company (2018-2023)
    8.2 Europe Drug Repurposing Market Size by Type
        8.2.1 Europe Drug Repurposing Sales Quantity by Type (2018-2030)
        8.2.2 Europe Drug Repurposing Revenue by Type (2018-2030)
    8.3 Europe Drug Repurposing Market Size by Application
        8.3.1 Europe Drug Repurposing Sales Quantity by Application (2018-2030)
        8.3.2 Europe Drug Repurposing Revenue by Application (2018-2030)
    8.4 Europe Drug Repurposing Market Size by Country
        8.4.1 Europe Drug Repurposing Revenue by Country: 2018 VS 2022 VS 2030
        8.4.2 Europe Drug Repurposing Revenue by Country (2018-2030)
        8.4.3 Europe Drug Repurposing Sales Quantity by Country (2018-2030)
        8.4.4 Germany
        8.4.5 France
        8.4.6 U.K.
        8.4.7 Italy
        8.4.8 Russia

 9 APAC
    9.1 APAC Drug Repurposing Sales by Company
        9.1.1 APAC Drug Repurposing Sales Quantity by Company (2018-2023)
        9.1.2 APAC Drug Repurposing Revenue by Company (2018-2023)
    10.2 APAC Drug Repurposing Market Size by Type
        9.2.1 APAC Drug Repurposing Sales Quantity by Type (2018-2030)
        9.2.2 APAC Drug Repurposing Revenue by Type (2018-2030)
    9.3 APAC Drug Repurposing Market Size by Application
        9.3.1 APAC Drug Repurposing Sales Quantity by Application (2018-2030)
        9.3.2 APAC Drug Repurposing Revenue by Application (2018-2030)
    9.4 APAC Drug Repurposing Market Size by Region
        9.4.1 APAC Drug Repurposing Revenue by Region: 2018 VS 2022 VS 2030
        9.4.2 APAC Drug Repurposing Revenue by Region (2018-2030)
        9.4.3 APAC Drug Repurposing Sales Quantity by Region (2018-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China
        9.4.7 Taiwan
        9.4.8 Southeast Asia
        9.4.9 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Drug Repurposing Sales by Company
        10.1.1 Middle East, Africa and Latin America Drug Repurposing Sales Quantity by Company (2018-2023)
        10.1.2 Middle East, Africa and Latin America Drug Repurposing Revenue by Company (2018-2023)
    10.2 Middle East, Africa and Latin America Drug Repurposing Market Size by Type
        10.2.1 Middle East, Africa and Latin America Drug Repurposing Sales Quantity by Type (2018-2030)
        10.2.2 Middle East, Africa and Latin America Drug Repurposing Revenue by Type (2018-2030)
    10.3 Middle East, Africa and Latin America Drug Repurposing Market Size by Application
        10.3.1 Middle East, Africa and Latin America Drug Repurposing Sales Quantity by Application (2018-2030)
        10.3.2 Middle East, Africa and Latin America Drug Repurposing Revenue by Application (2018-2030)
    10.4 Middle East, Africa and Latin America Drug Repurposing Market Size by Country
        10.4.1 Middle East, Africa and Latin America Drug Repurposing Revenue by Country: 2018 VS 2022 VS 2030
        10.4.2 Middle East, Africa and Latin America Drug Repurposing Revenue by Country (2018-2030)
        10.4.3 Middle East, Africa and Latin America Drug Repurposing Sales Quantity by Country (2018-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Israel
        10.4.8 GCC Countries

 11 Company Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Company Information
        11.1.2 Novartis AG Overview
        11.1.3 Novartis AG Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.1.4 Novartis AG Drug Repurposing Products and Services
        11.1.5 Novartis AG Drug Repurposing SWOT Analysis
        11.1.6 Novartis AG Recent Developments
    
11.2 Sandoz
        11.2.1 Sandoz Company Information
        11.2.2 Sandoz Overview
        11.2.3 Sandoz Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.2.4 Sandoz Drug Repurposing Products and Services
        11.2.5 Sandoz Drug Repurposing SWOT Analysis
        11.2.6 Sandoz Recent Developments
    
11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Information
        11.3.2 Johnson & Johnson Overview
        11.3.3 Johnson & Johnson Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.3.4 Johnson & Johnson Drug Repurposing Products and Services
        11.3.5 Johnson & Johnson Drug Repurposing SWOT Analysis
        11.3.6 Johnson & Johnson Recent Developments
    
11.4 IBM
        11.4.1 IBM Company Information
        11.4.2 IBM Overview
        11.4.3 IBM Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.4.4 IBM Drug Repurposing Products and Services
        11.4.5 IBM Drug Repurposing SWOT Analysis
        11.4.6 IBM Recent Developments
    
11.5 ABBOTT HEALTHCARE
        11.5.1 ABBOTT HEALTHCARE Company Information
        11.5.2 ABBOTT HEALTHCARE Overview
        11.5.3 ABBOTT HEALTHCARE Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.5.4 ABBOTT HEALTHCARE Drug Repurposing Products and Services
        11.5.5 ABBOTT HEALTHCARE Drug Repurposing SWOT Analysis
        11.5.6 ABBOTT HEALTHCARE Recent Developments
    
11.6 Teva Pharmaceuticals
        11.6.1 Teva Pharmaceuticals Company Information
        11.6.2 Teva Pharmaceuticals Overview
        11.6.3 Teva Pharmaceuticals Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.6.4 Teva Pharmaceuticals Drug Repurposing Products and Services
        11.6.5 Teva Pharmaceuticals Drug Repurposing SWOT Analysis
        11.6.6 Teva Pharmaceuticals Recent Developments
    
11.7 Pfizer Inc.
        11.7.1 Pfizer Inc. Company Information
        11.7.2 Pfizer Inc. Overview
        11.7.3 Pfizer Inc. Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.7.4 Pfizer Inc. Drug Repurposing Products and Services
        11.7.5 Pfizer Inc. Drug Repurposing SWOT Analysis
        11.7.6 Pfizer Inc. Recent Developments
    
11.8 Mylan Inc.
        11.8.1 Mylan Inc. Company Information
        11.8.2 Mylan Inc. Overview
        11.8.3 Mylan Inc. Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.8.4 Mylan Inc. Drug Repurposing Products and Services
        11.8.5 Mylan Inc. Drug Repurposing SWOT Analysis
        11.8.6 Mylan Inc. Recent Developments
    
11.9 HOFFMANN-LA ROCHE
        11.9.1 HOFFMANN-LA ROCHE Company Information
        11.9.2 HOFFMANN-LA ROCHE Overview
        11.9.3 HOFFMANN-LA ROCHE Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.9.4 HOFFMANN-LA ROCHE Drug Repurposing Products and Services
        11.9.5 HOFFMANN-LA ROCHE Drug Repurposing SWOT Analysis
        11.9.6 HOFFMANN-LA ROCHE Recent Developments
   
 11.10 Astellas Pharma Inc.
        11.10.1 Astellas Pharma Inc. Company Information
        11.10.2 Astellas Pharma Inc. Overview
        11.10.3 Astellas Pharma Inc. Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.10.4 Astellas Pharma Inc. Drug Repurposing Products and Services
        11.10.5 Astellas Pharma Inc. Drug Repurposing SWOT Analysis
        11.10.6 Astellas Pharma Inc. Recent Developments
    
11.11 Biovista
        11.11.1 Biovista Company Information
        11.11.2 Biovista Overview
        11.11.3 Biovista Drug Repurposing Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
        11.11.4 Biovista Drug Repurposing Products and Services
        11.11.5 Biovista Drug Repurposing SWOT Analysis
        11.11.6 Biovista Recent Developments
 
11.12 AbbVie Inc.
11.13 Allergan Plc.
11.14 NuMedii

12 Industry Chain and Sales Channels Analysis
    12.1 Drug Repurposing Industry Chain Analysis
    12.2 Drug Repurposing Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Drug Repurposing Production Mode & Process
    12.4 Drug Repurposing Sales and Marketing
        12.4.1 Drug Repurposing Sales Channels
        12.4.2 Drug Repurposing Distributors
    12.5 Drug Repurposing Customers

 13 Market Dynamics
    13.1 Drug Repurposing Industry Trends
    13.2 Drug Repurposing Market Drivers
    13.3 Drug Repurposing Market Challenges
    13.4 Drug Repurposing Market Restraints

 14 Key Findings

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com